Neuroinflammation and Aβ Accumulation Linked To Systemic Inflammation Are Decreased By Genetic PKR Down-Regulation
暂无分享,去创建一个
Claire Paquet | Raymond Chuen-Chung Chang | Laura Ravasi | R. Chang | S. Gourmaud | J. Hugon | L. Ravasi | C. Paquet | Jacques Hugon | M. Tible | Anne-Sophie Carret-Rebillat | Clarisse Pace | Sarah Gourmaud | Samantha Montagne-Stora | Sophie Longueville | Marion Tible | Erika Sudol | François Mouton-Liger | F. Mouton-Liger | Clarisse Pace | Anne-Sophie Carret-Rebillat | Sophie Longueville | Samantha Montagne-Stora | E. Sudoł
[1] J. Hardy,et al. The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .
[2] V. Perry,et al. Microglia in neurodegenerative disease , 2010, Nature Reviews Neurology.
[3] N. Sonenberg,et al. The protein kinase PKR: a molecular clock that sequentially activates survival and death programs , 2004, The EMBO journal.
[4] V. Perry,et al. Proinflammatory cytokines, sickness behavior, and Alzheimer disease , 2011, Neurology.
[5] R. Chang,et al. Could PKR inhibition modulate human neurodegeneration? , 2009, Expert review of neurotherapeutics.
[6] K. Tracey,et al. Novel role of PKR in inflammasome activation and HMGB1 release , 2012, Nature.
[7] C. Bouras,et al. Oxidative stress increases BACE1 protein levels through activation of the PKR-eIF2α pathway. , 2012, Biochimica et biophysica acta.
[8] R. Chang,et al. Phosphorylation of eukaryotic initiation factor-2alpha (eIF2alpha) is associated with neuronal degeneration in Alzheimer's disease. , 2002, Neuroreport.
[9] P. Mcgeer,et al. Neuroinflammation in Alzheimer's disease and mild cognitive impairment: a field in its infancy. , 2010, Journal of Alzheimer's disease : JAD.
[10] E. Meurs,et al. The N-terminus of PKR is responsible for the activation of the NF-kappaB signaling pathway by interacting with the IKK complex. , 2006, Cellular signalling.
[11] D. Borchelt,et al. Lipopolysaccharide-induced-neuroinflammation increases intracellular accumulation of amyloid precursor protein and amyloid β peptide in APPswe transgenic mice , 2003, Neurobiology of Disease.
[12] R. Chang,et al. Involvement of double‐stranded RNA‐dependent protein kinase and phosphorylation of eukaryotic initiation factor‐2α in neuronal degeneration , 2002, Journal of neurochemistry.
[13] Bryan Maloney,et al. Transcriptional Regulation of β-Secretase by p25/cdk5 Leads to Enhanced Amyloidogenic Processing , 2008, Neuron.
[14] H. Engler,et al. Endotoxin-induced experimental systemic inflammation in humans: A model to disentangle immune-to-brain communication , 2014, Brain, Behavior, and Immunity.
[15] G. Page,et al. The specific PKR inhibitor C16 prevents apoptosis and IL-1β production in an acute excitotoxic rat model with a neuroinflammatory component , 2014, Neurochemistry International.
[16] E. Meurs,et al. PKR Stimulates NF-κB Irrespective of Its Kinase Function by Interacting with the IκB Kinase Complex , 2000, Molecular and Cellular Biology.
[17] F. LaFerla,et al. Lipopolysaccharide-Induced Inflammation Exacerbates Tau Pathology by a Cyclin-Dependent Kinase 5-Mediated Pathway in a Transgenic Model of Alzheimer's Disease , 2005, The Journal of Neuroscience.
[18] M. Esteban,et al. The interferon-induced protein kinase (PKR), triggers apoptosis through FADD-mediated activation of caspase 8 in a manner independent of Fas and TNF-α receptors , 2000, Oncogene.
[19] A. Aguzzi,et al. Deficient signaling in mice devoid of double‐stranded RNA‐dependent protein kinase. , 1995, The EMBO journal.
[20] Wei Huang,et al. Suppression of PKR Promotes Network Excitability and Enhanced Cognition by Interferon-γ-Mediated Disinhibition , 2011, Cell.
[21] A. Mosig,et al. Automatic counting and positioning of 5-bromo-2-deoxyuridine (BrdU) positive cells in cortical layers of rat brain slices. , 2014, Neurotoxicology.
[22] J. Marchal,et al. The impact of PKR activation: from neurodegeneration to cancer , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[23] V. Perry,et al. Systemic inflammation and disease progression in Alzheimer disease , 2009, Neurology.
[24] R. Chang,et al. Phosphorylation of eukaryotic initiation factor-2&agr; (eIF2&agr;) is associated with neuronal degeneration in Alzheimer's disease , 2002, Neuroreport.
[25] J. Laplanche,et al. Cerebrospinal Fluid PKR Level Predicts Cognitive Decline in Alzheimer’s Disease , 2013, PloS one.
[26] Marie-Claude Potier,et al. Classification and basic pathology of Alzheimer disease , 2009, Acta Neuropathologica.
[27] F. Mormann,et al. Sepsis causes neuroinflammation and concomitant decrease of cerebral metabolism , 2008, Journal of Neuroinflammation.
[28] M. Chumley,et al. Prolonged elevation in hippocampal Aβ and cognitive deficits following repeated endotoxin exposure in the mouse , 2012, Behavioural Brain Research.
[29] J. Laplanche,et al. Increased Cerebrospinal Fluid Levels of Double-Stranded RNA-Dependant Protein Kinase in Alzheimer's Disease , 2012, Biological Psychiatry.
[30] B. Williams,et al. Protein kinase R and the inflammasome. , 2014, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[31] Huali Wang,et al. Cognitive function of first-episode late-onset depression among Chinese elderly , 2009, Alzheimer's & Dementia.
[32] D. Bennett,et al. Phosphorylation of the Translation Initiation Factor eIF2α Increases BACE1 Levels and Promotes Amyloidogenesis , 2008, Neuron.
[33] P. Osten,et al. Genetic Inhibition of Phosphorylation of the Translation Initiation Factor eIF2α Does Not Block Aβ-Dependent Elevation of BACE1 and APP Levels or Reduce Amyloid Pathology in a Mouse Model of Alzheimer’s Disease , 2014, PloS one.
[34] Urs Meyer,et al. Systemic immune challenges trigger and drive Alzheimer-like neuropathology in mice , 2012, Journal of Neuroinflammation.
[35] M. Pfaffl,et al. A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.
[36] S. Ferreira,et al. Inflammation, Defective Insulin Signaling, and Mitochondrial Dysfunction as Common Molecular Denominators Connecting Type 2 Diabetes to Alzheimer Disease , 2014, Diabetes.
[37] C. Moussa,et al. Inflammation in the early stages of neurodegenerative pathology , 2011, Journal of Neuroimmunology.